samedan logo

 
 
spacer
home > news
INDUSTRY NEWS AND PRESS RELEASES

Synthego Launches Engineered Cell Libraries to Validate Targets with Speed and Accelerate Drug Discovery

Novel CRISPR solution leverages Eclipse™ Platform to enable a faster path to therapeutic development

Aug 02, REDWOOD CITY, Calif. – Synthego, the genome engineering company, today announced the launch of Engineered Cell Libraries, a novel offering that further enables access to CRISPR by providing arrayed CRISPR-edited cells for direct use in functional screening assays. The innovative solution leverages Synthego’s Eclipse™ Platform. This high-throughput cell engineering platform delivers cell-based models for disease research by providing highly predictable CRISPR-engineered cells at scale through the integration of engineering, bioinformatics, and proprietary science. Synthego’s Engineered Cell Libraries provide unparalleled speed, scalability, and efficiency to accelerate the drug discovery process by enabling a faster path between experimental design and execution. More>>

 
phone +1 888-611-6883
web www.synthego.com/
email 3696 Haven Ave Suite A, Redwood City, CA 94063
 

Datwyler to Double Capacity at its Indian Facility

Datwyler is increasing capacity for all three of its production standards in Pune, India. The expansion will nearly double capacity and add 400 jobs. More>>

 
phone +41 41 875 11 23
email info@datwyler.com
web https://datwyler.com/
email Militärstrasse 7 CH-6467 Schattdorf
 

BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology

HEIDELBERG, Germany, August 1, 2022 / B3C newswire / -- BioMed X, a German independent research institute, announces the start of its new research project ‘Extrachromosomal DNA in Cancer’ (EDC) in collaboration with Healthcare Business of Merck KGaA, Darmstadt, Germany. The main objective of this research group is to develop an atlas of extrachromosomal DNA (ecDNA) in human cancer tissues and thereby trace back the mechanisms of ecDNA formation and function. More>>

 
phone +49 6221 426 11 0
email info@bio.mx
web bio.mx/
email BioMed X GmbH Im Neuenheimer Feld 515 69120 Heidelberg
 

Can Packaging Serialisation Be As Simple As 1,2,3?

For businesses that operate in the pharmaceutical and health categories, traceability, safety, and security are top priorities when designing packaging. More>>

 
email info@essentrapackaging.com
web www.essentrapackaging.com
 

Gerresheimer Awarded EcoVadis Gold for Sustainable Corporate Management for the First Time

More>>

 
phone +49-(0)211/61 81-00
email info@gerresheimer.com
web www.gerresheimer.com
email Klaus-Bungert-Str. 4, 40468 Duesseldorf, Germany
 

DSV and Ørsted to Test Cargo Drones at Anholt Offshore Wind Farm

DSV, the global Danish transport and logistics company, and Ørsted, the world-leading Danish energy company, will test long-distance drone transport of spare parts and tools in the Kattegat Sea in Denmark. More>>

 
web www.dsv.com
email Hovedgaden 630, PO Box 210, Hedehusene, 2640 Denmark
 

U.S. Alliance Pharma Acquires U.K.-based LGC’s Drug Development Solutions (DDS) Business

Expands bioanalytical services to include many emerging areas worldwide. More>>

 
phone 610-296-3152
email info@alliancepharmaco.com
web https://www.alliancepharmaco.com/
email 17 Lee Boulevard, Malvern, PA 19355
 

Datwyler Launches 5/8-Inch Rigid Needle Shield, Infusion Discs

New solutions expand the company’s portfolio of elastomer components to meet growing and changing patient needs

Altdorf, Switzerland, 11 July 2022— Datwyler, a leading manufacturer of elastomer components for pharmaceutical packaging, is expanding its portfolio with two new products to meet evolving patient demands. The new offerings include a 5/8 in. rigid needle shield (RNS) to address the rising need for prefilled syringes to contain vaccines for intramuscular injection, and isoprene rubber discs for infusion therapies. More>>

 
phone +41 41 875 11 23
email info@datwyler.com
web https://datwyler.com/
email Militärstrasse 7 CH-6467 Schattdorf
 

Signant Strengthens Digitally Optimized Trial Strategy with Delivery of Study Supplies Direct to Patients’ Homes

Signant Health, the leader in evidence generation for modern clinical trials, announced today enhancements to its Randomization and Trial Supply Management (RTSM) platform to enable direct-to-patient clinical supply distribution. More>>

 
phone +1 267 498 2300
email media@signanthealth.com
web https://signanthealth.com/
email 4000 Chemical Road Suite 300 Plymouth Meeting, PA 19462
 

Connect in Pharma Launches Art Exhibition and Charity Partnership to Raise Funds for Rare Disease Research

Geneva-based event pledges five Swiss francs per visitor to support new drug development project. More>>

 
phone +32 (0)2 740 10 70
email contactus@easyfairs.com
web www.connectinpharma.com
email Rue Saint-Lambert 135 1200 Brussels
 
spacer
News and Press Releases

AffyXell Expands its Strategic Partnership with GenScript ProBio

London and Wetherby, UK, 16 May 2022: Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company developing innovative cancer therapies and powerful diagnostics based on its proprietary pre|CISION™ and Affimer® platforms, is pleased to announce that AffyXell, its joint venture with South Korean drug maker Daewoong Pharmaceutical, has expanded its strategic partnership with GenScript ProBio, a leading biopharmaceutical manufacturer.
More info >>


White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>

Industry Events

Connect in Pharma

14-15 September 2022, Plaexpo, Geneva, Switzerland

The new event driving innovation for pharma and biopharma businesses, Connect in Pharma will unite key players in Pharmaceutical and Biopharmaceutical packaging and production in Geneva on 14 – 15 September 2022.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement